Oscar Fernández Cantero

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs

Carolyn S.P. Lam, Shun Kohsaka, Avraham Karasik et al. · Journal of the American College of Cardiology · 2018 · 466 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Observational data for comparative effectiveness research: An emulation of randomised trials of statins and primary prevention of coronary heart disease

Goodarz Danaei, Luis A. Garcı́a Rodrı́guez, Oscar Fernández Cantero et al. · Statistical Methods in Medical Research · 2011 · 285 citations · Full text

Public Health, Biostatistics, Pharmacotherapy +17

SGLT-2 Inhibitors and Cardiovascular Risk

Matthew A. Cavender, Anna Norhammar, Kåre I. Birkeland et al. · Journal of the American College of Cardiology · 2018 · 129 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Electronic medical records can be used to emulate target trials of sustained treatment strategies

Goodarz Danaei, Luis A. Garcı́a Rodrı́guez, Oscar Fernández Cantero et al. · Journal of Clinical Epidemiology · 2017 · 123 citations

Computing, Biomedical Informatics, Health Informatics +16

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

Shun Kohsaka, Carolyn S.P. Lam, Dae Jung Kim et al. · The Lancet Diabetes & Endocrinology · 2020 · 93 citations · Full text

Medicine, Cardiology, Pharmacology +12